VEOMARQ Trademark

Trademark Overview

On Monday, December 26, 2016, a trademark application was filed for VEOMARQ with the United States Patent and Trademark Office. The USPTO has given the VEOMARQ trademark a serial number of 87280935. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 6, 2020. This trademark is owned by Novartis AG. The VEOMARQ trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems
veomarq

General Information

Serial Number87280935
Word MarkVEOMARQ
Filing DateMonday, December 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements

Goods and ServicesDrug delivery systems

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, January 9, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, July 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2019EXTENSION 5 GRANTED
Sunday, November 24, 2019EXTENSION 5 FILED
Monday, December 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, November 24, 2019TEAS EXTENSION RECEIVED
Friday, May 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2019EXTENSION 4 GRANTED
Wednesday, May 29, 2019EXTENSION 4 FILED
Wednesday, May 29, 2019TEAS EXTENSION RECEIVED
Tuesday, November 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 24, 2018EXTENSION 3 GRANTED
Saturday, November 24, 2018EXTENSION 3 FILED
Saturday, November 24, 2018TEAS EXTENSION RECEIVED
Thursday, May 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 29, 2018EXTENSION 2 GRANTED
Tuesday, May 29, 2018EXTENSION 2 FILED
Tuesday, May 29, 2018TEAS EXTENSION RECEIVED
Friday, November 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 22, 2017EXTENSION 1 GRANTED
Wednesday, November 22, 2017EXTENSION 1 FILED
Wednesday, November 22, 2017TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017ASSIGNED TO EXAMINER
Monday, January 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

veomarq systems delivery drug